A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
Completed · Phase 3
Conditions studied: General Anxiety Disorder, Social Anxiety Disorder
In brief
This study is being conducted to evaluate the safety and effectiveness of memantine Add-On treatment of patients who are currently taking an SNRI or SSRI and who remain anxious and symptomatic despite treatment. Secondary objectives of this study are: •-to evaluate if there is an improvement in disability levels following memantine dosing -to evaluate if there is an improvement in sleep quality following memantine dosing
Key facts
- Study ID
- NCT00411398
- Run by
- State University of New York - Upstate Medical University
- People needed
- 15
- Starts
- 2006-12-01
- Expected to finish
- 2010-05-01
- Last updated by the study team
- 2014-12-10
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.
Where it is running
- SUNY Upstate Medical University Psychiatry Dept. — Syracuse, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.